Reviewer Board
Members of the reviewer board are selected from all Cancers reviewers for regularly providing timely high quality reports on submitted manuscripts. Responsibilities of reviewers are available here.
Members
1. Departamento de Farmacología, Fisiología y Medicina Legal y Forense, Facultad de Veterinaria, Universidad de Zaragoza, Miguel Servet, 177, 50013 Zaragoza, Spain
2. Instituto de Investigación Sanitaria de Aragón (IIS Aragón), 50009 Zaragoza, Spain
3. Instituto Agroalimentario de Aragón IA2, Universidad de Zaragoza-CITA, 50013 Zaragoza, Spain
Interests: colon cancer; microbiota; oxidative stress; intestine; antibiotics; metallodrugs; intestinal motility; inflammatory bowel disease; bioactive compounds
2. Instituto de Investigación Sanitaria de Aragón (IIS Aragón), 50009 Zaragoza, Spain
3. Instituto Agroalimentario de Aragón IA2, Universidad de Zaragoza-CITA, 50013 Zaragoza, Spain
Interests: colon cancer; microbiota; oxidative stress; intestine; antibiotics; metallodrugs; intestinal motility; inflammatory bowel disease; bioactive compounds
Weston Park Cancer Centre, Department of Oncology & Metabolism and Mellanby Centre for Bone Research, The University of Sheffield, Sheffield S10 2TT, UK
Interests: multiple myeloma; bone marrow microenvironment; cancer-induced bone disease; bone metastasis; retinoic acid receptors
Interests: multiple myeloma; bone marrow microenvironment; cancer-induced bone disease; bone metastasis; retinoic acid receptors
Department of Pharmaceutical Sciences, Università del Piemonte Orientale “Amedeo Avogadro”, 28100 Novara, Italy
Interests: NAD metabolism; cancer; breast cancer; angiogenesis; pericytes; molecular biology; pharmacology; basic research
Interests: NAD metabolism; cancer; breast cancer; angiogenesis; pericytes; molecular biology; pharmacology; basic research
1. Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel
2. Lady Davis Carmel Medical Center, Clalit Health Services, Haifa, Israel
Interests: pharmacoepidemiology; personalized medicine; implementation of genomic medicine; clinical recommendations drawn from pharmacogenetic test results
2. Lady Davis Carmel Medical Center, Clalit Health Services, Haifa, Israel
Interests: pharmacoepidemiology; personalized medicine; implementation of genomic medicine; clinical recommendations drawn from pharmacogenetic test results
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06511, USA
Interests: proton therapy; Particle therapy; radiobiology; microdosimetry; monte carlo; Geant4
Interests: proton therapy; Particle therapy; radiobiology; microdosimetry; monte carlo; Geant4
Arcus Biosciences
3928 Point Eden Way, Hayward, CA 94545
Interests: ascorbic acid; Blood Cancer; Demethylation; DNA Dioxygenase; Tet2; drug development; development biology; epigenetics; p53; leukemia; blood
Interests: ascorbic acid; Blood Cancer; Demethylation; DNA Dioxygenase; Tet2; drug development; development biology; epigenetics; p53; leukemia; blood
IRCCS Azienda Unità Sanitaria Locale di Reggio Emilia, Reggio Emilia, Italy
Interests: transcription regulation; EMT; lncRNAs; autophagy; metastases; Thyroid Cancer; breast cancer; melanoma
Interests: transcription regulation; EMT; lncRNAs; autophagy; metastases; Thyroid Cancer; breast cancer; melanoma
Department of Surgery, Boston University School of Medicine, Boston, MA, USA
Interests: cancer immunotherapy; gene therapy; tumor microenvironment; Immunosuprression; signal transduction; transcriptional regulation
Interests: cancer immunotherapy; gene therapy; tumor microenvironment; Immunosuprression; signal transduction; transcriptional regulation
Istituto Nazionale Tumori IRCCS - Fondazione G Pascale, Napoli, 80131 Naples, Italy
Interests: oral cancer; medication related osteonecrosis of the jaw; oral surgery; oral precancerosis; oral medicine
Interests: oral cancer; medication related osteonecrosis of the jaw; oral surgery; oral precancerosis; oral medicine
Department of Biochemistry and Molecular Biology & The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA
Interests: cancer; metabolism; mass spectrometry; therapy; resistance; angiogenesis; extracellular matrix
Interests: cancer; metabolism; mass spectrometry; therapy; resistance; angiogenesis; extracellular matrix
Department of Pharmacology and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77204, USA
Interests: colon cancer; prostate cancer; miRNA; lncRNA; epigenetics; apoptosis; chemotherapy; cancer biology
Interests: colon cancer; prostate cancer; miRNA; lncRNA; epigenetics; apoptosis; chemotherapy; cancer biology
1. Clinic of Hematology, Department of Internal Medicine (DIMI), University of Genoa, 16132 Genova, Italy
2. IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy
Interests: acute myeloid leukemia; acute lymphoblastic leukemia; stem cell transplantation; minimal residual disease assessment adoptive immunotherapy
2. IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy
Interests: acute myeloid leukemia; acute lymphoblastic leukemia; stem cell transplantation; minimal residual disease assessment adoptive immunotherapy
Department of developmental and molecular biology, Albert Einstein College of Medicine, 1300 Morris Park Ave, The Bronx, NY 10461, USA
Interests: Multi-drug resistance; targeted therapy; chemotherapy; oncogenic signaling; ABC transporters; Cell Death; lung cancer; prostate cancer; leukemia
Interests: Multi-drug resistance; targeted therapy; chemotherapy; oncogenic signaling; ABC transporters; Cell Death; lung cancer; prostate cancer; leukemia
University of Nebraska Medical Center, Omaha, NE 68198, USA
Interests: cancer metastasis; therapeutics; biomarkers; tumor microenvironment; autophagy; cell signaling; immunotherapy; exosomes; solid tumors
Interests: cancer metastasis; therapeutics; biomarkers; tumor microenvironment; autophagy; cell signaling; immunotherapy; exosomes; solid tumors
Post-Doctoral Scholar Research Associate, Norris Comprehensive Cancer Center, University of Southern California, 1441 Eastlake Ave., NOR 5312, Los Angeles, CA 90089, USA
Interests: cell biology; cancer biology; virology; er stress; unfolded protein response; biochemistry; molecular biology; GRP78; BIP; chaperones; drug development; carcinogenesis
Interests: cell biology; cancer biology; virology; er stress; unfolded protein response; biochemistry; molecular biology; GRP78; BIP; chaperones; drug development; carcinogenesis
Medical Oncologist, Endocrine oncology, Imaging department, Gustave Roussy, 114 rue Edouard Vaillant, 94800 Villejuif, France
Interests: neuroendocrine tumors; pheochromocytoma; paraganglioma; Thyroid Cancer; medullary thyroid carcinoma; Adrenal Carcinoma
Interests: neuroendocrine tumors; pheochromocytoma; paraganglioma; Thyroid Cancer; medullary thyroid carcinoma; Adrenal Carcinoma
Department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Dentistry, Suita, Osaka 565-0871, Japan
Interests: oral cancer; molecular targeting therapy; apoptosis; autophagy; Cell Death
Interests: oral cancer; molecular targeting therapy; apoptosis; autophagy; Cell Death
Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University, Taipei 11031, Taiwan
Interests: mass spectrometry analysis; proteomics; proteogenomics; cancer research; biomarker discovery
Interests: mass spectrometry analysis; proteomics; proteogenomics; cancer research; biomarker discovery
Center for Personalized Cancer Therapy, University of Massachusetts Boston, 100 Morrissey Blvd, Boston, MA 02125, USA
Interests: prostate cancer; androgen receptor; transcriptional repression; castration-resistant prostate cancer
Interests: prostate cancer; androgen receptor; transcriptional repression; castration-resistant prostate cancer
Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
Interests: exosomes; extracellular vesicles; Non-coding RNA; tumor microenvironment; breast and gynecologic cancers
Interests: exosomes; extracellular vesicles; Non-coding RNA; tumor microenvironment; breast and gynecologic cancers
1. Institute for Quantitative Health Science and Engineering (IQ), Michigan State University, East Lansing, MI 48824, USA
2. Department of Biomedical Engineering, Michigan State University, East Lansing, MI 48824, USA
Interests: miRNA; cancer; diabetes; targeted therapy; dna; epigenetics; therapeutic vector; molecular screening
2. Department of Biomedical Engineering, Michigan State University, East Lansing, MI 48824, USA
Interests: miRNA; cancer; diabetes; targeted therapy; dna; epigenetics; therapeutic vector; molecular screening
Department of Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
Interests: colorectal cancer, gastric cancer, esophageal cancer, mechanisms of remote ischemic preconditioning, quality assurance in surgical oncology
Interests: colorectal cancer, gastric cancer, esophageal cancer, mechanisms of remote ischemic preconditioning, quality assurance in surgical oncology
Université de Lorraine CNRS UMR 7039 CRAN, Service de Biopathologie, Institut de Cancérologie de Lorraine, F-54519, Vandœuvre-lès-Nancy, France
Interests: cell-free DNA; biomarkers; molecular diagnosis; HPV; pancreatic cancer
Interests: cell-free DNA; biomarkers; molecular diagnosis; HPV; pancreatic cancer
Department of Geography, Macalester College, Saint Paul, MN 55105, USA
Interests: NDVI; land-cover change; tropical andes; biodiversity; Latin America; time series analysis; vegetation greening and browning
Interests: NDVI; land-cover change; tropical andes; biodiversity; Latin America; time series analysis; vegetation greening and browning
National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD, USA
Interests: ovarian cancer; cancer stem cells; cdcp1; nfkb; aldh; metastasis; patient derived xenograft; synthetic lethality
Interests: ovarian cancer; cancer stem cells; cdcp1; nfkb; aldh; metastasis; patient derived xenograft; synthetic lethality
Department of Molecular, Biology of Cancer, Medical University of Lodz, Mazowiecka Street 6/8, 92215 Lodz, Poland
Interests: melanoma; cancer heterogeneity; microenvironment; growth factors; therapy resistance; apoptosis; transcription factors; anticancer drugs; MITF; BH3 mimetics; BRAF; targeted therapy; transcriptomics; whole-exome sequencing; cell transfection
Interests: melanoma; cancer heterogeneity; microenvironment; growth factors; therapy resistance; apoptosis; transcription factors; anticancer drugs; MITF; BH3 mimetics; BRAF; targeted therapy; transcriptomics; whole-exome sequencing; cell transfection
Department of Gynecologic Oncology, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka, Saitama 350-1298, Japan
Interests: ovarian cancer; endometiral cancer; cervical cancer; immunotherapy; tumor marker; drug development
Interests: ovarian cancer; endometiral cancer; cervical cancer; immunotherapy; tumor marker; drug development
Biology Department, Utica College, Utica, New York, NY 13502, USA
Interests: nutritional epidemiology; esophageal cancer; gastric cancer; non-alcoholic fatty liver disease; diet
Interests: nutritional epidemiology; esophageal cancer; gastric cancer; non-alcoholic fatty liver disease; diet
Department of Orthopaedics Surgery, Kindai University Hospital, Osaka 589-8511, Japan
Interests: musculoskeletal oncology
Interests: musculoskeletal oncology
Department of Translational Hematology and Oncology Research, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH 44195, USA
Interests: multiple myeloma; myeloid neoplasia; DNA damage; thrombosis
Interests: multiple myeloma; myeloid neoplasia; DNA damage; thrombosis
